Gender, low initial platelet count, unsatisfactory coagulation profile, presence of FLT3-ITD mutation, and initiating steroid with ATRA to reduce the incidence of DS were not considered poor prognostic factors for causing early death, with no significant P-value, Table 3. This evidence concerns the gene FLT3 and Dravet syndrome.